Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- UXIN +15.5%, BBWI +13%
Other news:
- NVX +22.8% (signs binding offtake agreement with PowerCo)
- BBIO +19.2% (reports Attruby (acoramidis), a Near Complete TTR Stabilizer (=90%), approved by FDA to Reduce Cardiovascular Death and Cardiovascular-related Hospitalization in ATTR-CM Patients)
- EVTL +7.5% (receives $50 million in new funding as part of $180 million transaction that will strengthen its financial position and advance its Flightpath 2030 Strategy)
- ORGO +5.7% (announces plans to expand its manufacturing capacity with new long-term lease for biomanufacturing facility in Rhode Island)
- MSTR +5.2% (Barron's out positive on MSTR)
- EQT +4.3% (confirms $3.5 billion midstream joint venture with Blackstone (BX) Credit & Insurance)
- NTLA +4.1% (FDA has granted Regenerative Medicine Advanced Therapy designation to nexiguran ziclumeran for the treatment of hereditary transthyretin amyloidosis with polyneuropathy)
- SMLR +2.9% (reports updated bitcoin and ATM activity; Company launches additional $50.0 mln ATM offering)
- ENLC +2.8% (ONEOK agrees to acquire remaining publicly held common units in EnLink midstream in a tax-free transaction)
- QSI +2.5% (announces organizational restructuring program, including workforce reduction)
- ALNY +2.5% (announces that the U.S. FDA has accepted for review the Company's supplemental New Drug Application for vutrisiran, an investigational RNAi therapeutic in development for the treatment of ATTR amyloidosis with cardiomyopathy)
- ETON +2.3% (acquires U.S. rights to Amglidia)
- POET +1.5% (announces its intention to expand its optical engine production capacity in Malaysia)
- GMED +1.4% (announces commercial launch of ExcelsiusHub navigation system)
- NNDM +1.4% (Leading Proxy Advisory Firm Glass Lewis Recommends Nano Dimension Shareholders Vote "FOR" Both of Murchinson's Independent Director Nominees)
- TXNM +1.3% (files application for new resources in 2028)
- CVE +1.2% (announces redemption of Series 3 Preferred Shares)
- NU +1.2% (receives approval to consolidate its operations under a single company)